Literature DB >> 24814956

cDNA hybrid capture improves transcriptome analysis on low-input and archived samples.

Christopher R Cabanski1, Vincent Magrini2, Malachi Griffith2, Obi L Griffith1, Sean McGrath3, Jin Zhang1, Jason Walker3, Amy Ly3, Ryan Demeter3, Robert S Fulton3, Winnie W Pong4, David H Gutmann5, Ramaswamy Govindan1, Elaine R Mardis6, Christopher A Maher7.   

Abstract

The use of massively parallel sequencing for studying RNA expression has greatly enhanced our understanding of the transcriptome through the myriad ways these data can be characterized. In particular, clinical samples provide important insights about RNA expression in health and disease, yet these studies can be complicated by RNA degradation that results from the use of formalin as a clinical preservative and by the limited amounts of RNA often available from these precious samples. In this study we describe the combined use of RNA sequencing with an exome capture selection step to enhance the yield of on-exon sequencing read data when compared with RNA sequencing alone. In particular, the exome capture step preserves the dynamic range of expression, permitting differential comparisons and validation of expressed mutations from limited and FFPE preserved samples, while reducing the data generation requirement. We conclude that cDNA hybrid capture has the potential to significantly improve transcriptome analysis from low-yield FFPE material.
Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24814956      PMCID: PMC4078367          DOI: 10.1016/j.jmoldx.2014.03.004

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  38 in total

Review 1.  Unlocking the archive--gene expression in paraffin-embedded tissue.

Authors:  F Lewis; N J Maughan; V Smith; K Hillan; P Quirke
Journal:  J Pathol       Date:  2001-09       Impact factor: 7.996

2.  Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing.

Authors:  Qun Pan; Ofer Shai; Leo J Lee; Brendan J Frey; Benjamin J Blencowe
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

3.  A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome.

Authors:  Marc Sultan; Marcel H Schulz; Hugues Richard; Alon Magen; Andreas Klingenhoff; Matthias Scherf; Martin Seifert; Tatjana Borodina; Aleksey Soldatov; Dmitri Parkhomchuk; Dominic Schmidt; Sean O'Keeffe; Stefan Haas; Martin Vingron; Hans Lehrach; Marie-Laure Yaspo
Journal:  Science       Date:  2008-07-03       Impact factor: 47.728

4.  Mapping and quantifying mammalian transcriptomes by RNA-Seq.

Authors:  Ali Mortazavi; Brian A Williams; Kenneth McCue; Lorian Schaeffer; Barbara Wold
Journal:  Nat Methods       Date:  2008-05-30       Impact factor: 28.547

5.  Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.

Authors:  Luca Gianni; Milvia Zambetti; Kim Clark; Joffre Baker; Maureen Cronin; Jenny Wu; Gabriella Mariani; Jaime Rodriguez; Marialuisa Carcangiu; Drew Watson; Pinuccia Valagussa; Roman Rouzier; W Fraser Symmans; Jeffrey S Ross; Gabriel N Hortobagyi; Lajos Pusztai; Steven Shak
Journal:  J Clin Oncol       Date:  2005-09-06       Impact factor: 44.544

6.  The Sequence Alignment/Map format and SAMtools.

Authors:  Heng Li; Bob Handsaker; Alec Wysoker; Tim Fennell; Jue Ruan; Nils Homer; Gabor Marth; Goncalo Abecasis; Richard Durbin
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

Review 7.  RNA-Seq: a revolutionary tool for transcriptomics.

Authors:  Zhong Wang; Mark Gerstein; Michael Snyder
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

8.  Transcriptome sequencing to detect gene fusions in cancer.

Authors:  Christopher A Maher; Chandan Kumar-Sinha; Xuhong Cao; Shanker Kalyana-Sundaram; Bo Han; Xiaojun Jing; Lee Sam; Terrence Barrette; Nallasivam Palanisamy; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-01-11       Impact factor: 49.962

9.  Alternative isoform regulation in human tissue transcriptomes.

Authors:  Eric T Wang; Rickard Sandberg; Shujun Luo; Irina Khrebtukova; Lu Zhang; Christine Mayr; Stephen F Kingsmore; Gary P Schroth; Christopher B Burge
Journal:  Nature       Date:  2008-11-27       Impact factor: 49.962

10.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Authors:  Daehwan Kim; Geo Pertea; Cole Trapnell; Harold Pimentel; Ryan Kelley; Steven L Salzberg
Journal:  Genome Biol       Date:  2013-04-25       Impact factor: 13.583

View more
  24 in total

1.  Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.

Authors:  Beatriz M Carreno; Vincent Magrini; Michelle Becker-Hapak; Saghar Kaabinejadian; Jasreet Hundal; Allegra A Petti; Amy Ly; Wen-Rong Lie; William H Hildebrand; Elaine R Mardis; Gerald P Linette
Journal:  Science       Date:  2015-04-02       Impact factor: 47.728

2.  Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity.

Authors:  Xiuli Zhang; Samuel Kim; Jasreet Hundal; John M Herndon; Shunqiang Li; Allegra A Petti; Savas D Soysal; Lijin Li; Mike D McLellan; Jeremy Hoog; Tina Primeau; Nancy Myers; Tammi L Vickery; Mark Sturmoski; Ian S Hagemann; Chris A Miller; Matthew J Ellis; Elaine R Mardis; Ted Hansen; Timothy P Fleming; S Peter Goedegebuure; William E Gillanders
Journal:  Cancer Immunol Res       Date:  2017-06-15       Impact factor: 11.151

3.  Characterization of splice-altering mutations in inherited predisposition to cancer.

Authors:  Silvia Casadei; Suleyman Gulsuner; Brian H Shirts; Jessica B Mandell; Hannah M Kortbawi; Barbara S Norquist; Elizabeth M Swisher; Ming K Lee; Yael Goldberg; Robert O'Connor; Zheng Tan; Colin C Pritchard; Mary-Claire King; Tom Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

4.  Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors.

Authors:  Julie W Reeser; Dorrelyn Martin; Jharna Miya; Esko A Kautto; Ezra Lyon; Eliot Zhu; Michele R Wing; Amy Smith; Matthew Reeder; Eric Samorodnitsky; Hannah Parks; Karan R Naik; Joseph Gozgit; Nicholas Nowacki; Kurtis D Davies; Marileila Varella-Garcia; Lianbo Yu; Aharon G Freud; Joshua Coleman; Dara L Aisner; Sameek Roychowdhury
Journal:  J Mol Diagn       Date:  2017-08-09       Impact factor: 5.568

5.  RNA-sequencing reveals oligodendrocyte and neuronal transcripts in microglia relevant to central nervous system disease.

Authors:  Anne C Solga; Winnie W Pong; Jason Walker; Todd Wylie; Vincent Magrini; Anthony J Apicelli; Malachi Griffith; Obi L Griffith; Shinichi Kohsaka; Gregory F Wu; David L Brody; Elaine R Mardis; David H Gutmann
Journal:  Glia       Date:  2014-09-24       Impact factor: 7.452

6.  Sequencing the AML genome, transcriptome, and epigenome.

Authors:  Elaine R Mardis
Journal:  Semin Hematol       Date:  2014-08-07       Impact factor: 3.851

Review 7.  Cancer transcriptome profiling at the juncture of clinical translation.

Authors:  Marcin Cieślik; Arul M Chinnaiyan
Journal:  Nat Rev Genet       Date:  2017-12-27       Impact factor: 53.242

8.  Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations.

Authors:  Dorrelyn P Martin; Jharna Miya; Julie W Reeser; Sameek Roychowdhury
Journal:  J Vis Exp       Date:  2016-08-04       Impact factor: 1.355

Review 9.  Clonotyping for precision oncology.

Authors:  Ha X Dang; Christopher A Maher
Journal:  Drug Discov Today       Date:  2015-10-19       Impact factor: 7.851

Review 10.  Tumor neoantigens: building a framework for personalized cancer immunotherapy.

Authors:  Matthew M Gubin; Maxim N Artyomov; Elaine R Mardis; Robert D Schreiber
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.